Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial

Jason Bacharach1 North Bay Eye Associates, Sonoma County, CA, USACorrespondence[email protected]
View further author information

Iqbal Ike K Ahmed2 John Moran Eye Center, University of Utah, Salt Lake City, UT, USAView further author information

Elizabeth D Sharpe3 Glaucoma Consultants and Center for Eye Research, Mt. Pleasant, SC, USAView further author information

Michael S Korenfeld4 Comprehensive Eye Care, Washington, MO, USA

https://orcid.org/0000-0003-1804-5525 View further author information

Steven Zhang5 Thea Pharma, Inc, Lexington, MA, USAView further author information

Christophe Baudouin6 Quinze-Vingts National Ophthalmology Hospital & Vision Institute, Paris Saclay-Versailles-Saint Quentin University, IHU Foresight, Paris, France

https://orcid.org/0000-0003-1743-6698 View further author information

Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Preservative-Free versus Benzalkonium Chloride–Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date